PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16856883-0	2006	The effects of human CYP2C8 genotype and fluvoxamine on the pharmacokinetics of rosiglitazone in healthy subjects.	Rosiglitazone	80-93	cytochrome P450 family 2 subfamily C member 8	Homo sapiens	21-27	
16856883-1	2006	AIMS: To determine the effect of CYP2C8 genotype and of fluvoxamine on the pharmacokinetics of rosiglitazone.	Rosiglitazone	95-108	cytochrome P450 family 2 subfamily C member 8	Homo sapiens	33-39	
16856883-10	2006	CONCLUSION: The importance of the CYP2C8*3 mutation in the in vivo metabolism of rosiglitazone could not be confirmed.	Rosiglitazone	81-94	cytochrome P450 family 2 subfamily C member 8	Homo sapiens	34-40